News & Perspective

Nov 07, 2003

Nov 07, 2003

Acambis launches clinical trial of West Nile vaccine

(CIDRAP News) – The British biotechnology company Acambis announced yesterday that it has launched the first clinical trial of its vaccine for West Nile virus, called ChimeriVax-West Nile.

The phase 1 trial will involve 60 adult volunteers in Lenexa, Kan., the company said in a news release. The volunteers will receive one of three doses of the West Nile vaccine or a licensed yellow fever vaccine that is being used as a control.